Zivo Bioscience Inc (OTCMKTS:ZIVO) Director Christopher D. Maggiore bought 116,000 shares of the business’s stock in a transaction dated Wednesday, February 14th. The shares were purchased at an average cost of $0.09 per share, with a total value of $10,440.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of Zivo Bioscience Inc (OTCMKTS ZIVO) traded up $0.00 during midday trading on Wednesday, reaching $0.11. 34,499 shares of the company traded hands, compared to its average volume of 210,093. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of -0.04. Zivo Bioscience Inc has a 12 month low of $0.05 and a 12 month high of $0.15.
COPYRIGHT VIOLATION NOTICE: “Zivo Bioscience Inc (ZIVO) Director Buys $10,440.00 in Stock” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2018/02/14/zivo-bioscience-inc-zivo-director-buys-10440-00-in-stock.html.
Zivo Bioscience, Inc, formerly Health Enhancement Products, Inc, is a biotechnology company. The Company is engaged in the study, development and commercialization of naturally derived compounds and bioactive molecules created by algal and bacterial hosts. The Company focuses on research and identification of its bioactive ingredients.
Receive News & Ratings for Zivo Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zivo Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.